T1期结直肠癌内镜局部切除后复发风险与时间模式的荟萃分析
结果显示任何复发 pooled 累积发生率为3.3%,高危T1为7.0%,低危T1为0.7%,绝大多数复发(95.6%)发生在随访72个月内。
要点
- 仅内镜切除的T1期结直肠癌任何复发 pooled 累积发生率为3.3%。
- 高危T1复发 pooled 发生率为7.0%,低危T1为0.7%。
- 95.6%的复发发生在随访72个月内,支持此期间加强监测。
核心结论
- 该荟萃分析提供了与T1期结直肠癌内镜局部切除后监测指南相关的定量结局指标。
研究设计与样本
- 系统检索PubMed、EMBASE、Web of Science和Cochrane Library(从建库至2020年5月15日),纳入描述仅内镜局部切除后局部或远处复发累积发生率的研究。
主要发现
- 任何结直肠癌复发的 pooled 累积发生率为3.3%(209例事件;95%CI,2.6%-4.3%;I2=54.9%)。
- 局部复发和远处复发的 pooled 发生率分别为1.9%和1.6%。
- 35项研究中2519例患者有42例发生结直肠癌相关死亡, pooled 发生率为1.7%(95%CI,1.2%-2.2%;I2=0%)。
- 复发患者中结直肠癌相关死亡率为40.8%(42/103例)。
- 绝大多数复发(95.6%)发生在随访72个月内。
关键数值与推荐
- 高危T1期结直肠癌任何复发的 pooled 发生率为7.0%(28项研究;95%CI,4.9%-9.9%;I2=48.1%)。
- 低危T1期结直肠癌任何复发的 pooled 发生率为0.7%(36项研究;95%CI,0.4%-1.2%;I2=0%)。
临床怎么用
- 对于仅接受内镜局部切除的T1期结直肠癌患者,应依据高危或低危分层制定监测策略。
- 鉴于95.6%的复发发生在72个月内,随访监测应重点覆盖该时间段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Growing numbers of patients with T1 CRC are being treated with local endoscopic resection only and as a result, the need for optimization of surveillance strategies for these patients also increases. We aimed to estimate the cumulative incidence and time pattern of CRC recurrences for endoscopically treated patients with T1 CRC. METHODS: Using a systematic literature search in PubMed, EMBASE, Web of Science and Cochrane Library (from inception till 15 May 2020), we identified and extracted data from studies describing the cumulative incidence of local or distant CRC recurrence for patients with T1 CRC treated with local endoscopic resection only. Pooled estimates were calculated using mixed-effect logistic regression models. RESULTS: Seventy-one studies with 5167 unique, endoscopically treated patients with T1 CRC were included. The pooled cumulative incidence of any CRC recurrence was 3.3% (209 events; 95% CI, 2.6%-4.3%; I2 = 54.9%), with local and distant recurrences being found at comparable rates (pooled incidences 1.9% and 1.6%, respectively). CRC-related mortality was observed in 42 out of 2519 patients (35 studies; pooled incidence 1.7%, 95% CI, 1.2%-2.2%; I2 = 0%), and the CRC-related mortality rate among patients with recurrence was 40.8% (42/103 patients). The vast majority of recurrences (95.6%) occurred within 72 months of follow-up. Pooled incidences of any CRC recurrence were 7.0% for high-risk T1 CRCs (28 studies; 95% CI, 4.9%-9.9%; I2 = 48.1%) and 0.7% (36 studies; 95% CI, 0.4%-1.2%; I2 = 0%) for low-risk T1 CRCs. CONCLUSIONS: Our meta-analysis provides quantitative outcome measures which are relevant to guidelines on surveillance after local endoscopic resection of T1 CRC.
引用
- Dang H, Dekkers N, le Cessie S, et al. Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis. Clin Gastroenterol Hepatol. 2020. PMID: 33271339. doi:10.1016/j.cgh.2020.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。